REPLIMUNE GROUP, INC.

REPL ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $543.1M

Liabilities Breakdown FY2021

Total Liabilities: $44.4M